Namibia - English - Namibia Medicines Regulatory Council

be-tabs pharmaceuticals (pty) ltd - erythromycine estolate - suspension - each 5 ml recons. suspension contains erythromycine estolate equiv. to erythromycine base 125mg

Canada - English - Health Canada

pro doc limitee - erythromycin stearate - tablet - 250mg - erythromycin stearate 250mg - erythromycins

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - lidocaine hydrochloride monohydrate - solution for injection - lidocaine hydrochloride monohydrate 20 mg/ml - lidocaine - local and regional anaesthesia.severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.

Canada - English - Health Canada

bio agri mix lp - erythromycin (erythromycin phosphate) - powder for solution - 115.6mg - erythromycin (erythromycin phosphate) 115.6mg - poultry; poultry

Ireland - English - HPRA (Health Products Regulatory Authority)

amdipharm limited - erythromycin - film-coated tablet - 500 milligram(s) - macrolides; erythromycin

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - timolol maleate - solution - 0.25 g/100 ml - timolol maleate 0.25 g/100 ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - timolol maleate - solution - 0.5 g/100 ml - timolol maleate 0.5 g/100 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - lidocaine hydrochloride - solution for injection in pre-filled syringe - 10 milligram(s)/millilitre - amides; lidocaine

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - lidocaine hydrochloride - solution for injection in pre-filled syringe - 20 milligram(s)/millilitre - amides; lidocaine

Israel - English - Ministry of Health

abic marketing ltd, israel - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan - * for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. * for the treatment of patients with small cell lung cancer.* for the treatment of patients with gastric cancer.* irinotecan in combination with leucovorin, oxaliplatin and 5-fluorouracil, for the first-line treatment of patients with metastatic pancreatic adenocarcinoma.